Goldman Sachs’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-224,159
| Closed | -$82.3K | – | 6405 |
|
|
2025
Q2 | $82.3K | Buy |
224,159
+147,513
| +192% | +$49.2K | ﹤0.01% | 5853 |
|
|
2025
Q1 | $19.9K | Sell |
76,646
-1,575,077
| -95% | -$899K | ﹤0.01% | 5942 |
|
|
2024
Q4 | $929K | Sell |
1,651,723
-2,336,749
| -59% | -$1.38M | ﹤0.01% | 4869 |
|
|
2024
Q3 | $2.39M | Buy |
3,988,472
+3,484,341
| +691% | +$5.17M | ﹤0.01% | 3993 |
|
|
2024
Q2 | $1.36M | Sell |
504,131
-46,948
| -9% | -$177K | ﹤0.01% | 4238 |
|
|
2024
Q1 | $2.83M | Buy |
+551,079
| New | +$1.79M | ﹤0.01% | 3592 |
|
|
2023
Q4 | – | Sell |
-55,878
| Closed | -$37K | – | 5674 |
|
|
2023
Q3 | $37K | Buy |
+55,878
| New | +$56.5K | ﹤0.01% | 5307 |
|
|
2022
Q1 | – | Sell |
-10,294
| Closed | -$62K | – | 6641 |
|
|
2021
Q4 | $62K | Buy |
+10,294
| New | +$71K | ﹤0.01% | 6227 |
|
|
2021
Q3 | – | Sell |
-62,500
| Closed | -$848K | – | 6300 |
|
|
2021
Q2 | $848K | Buy |
+62,500
| New | +$773K | ﹤0.01% | 4882 |
|
